Reopened Chinese hearing aid market is difficult to predict, says Demant CEO

Though pent-up demand in China is a given after pandemic restrictions have lapsed, a number of factors make it difficult to assess the actual potential, says Demant CEO Søren Nielsen.
Søren Nielsen, CEO of Demant | Photo: Demant / Pr
Søren Nielsen, CEO of Demant | Photo: Demant / Pr
by albert rønning-andersson, translated by daniel pedersen

Hearing aid manufacturer Demant had an awful 2022 in China, and a pretty tough start to 2023 in the country as well. After a domestic zero-tolerance Covid-19 policy was dropped in December, though, things are somewhat improving, says Chief Executive Søren Nielsen to MedWatch.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading